By: Benzinga
UPDATE: Goldman Sachs Downgrades Universal American Corporation to Sell on Medicare Advantage Risk
Goldman Sachs reduced its rating on Universal American Corporation (NYSE: UAM ) from Neutral to Sell with an $8 price target. Goldman Sachs noted, "We downgrade Universal American to Sell from Neutral, reflecting our view of downside risk to earnings from its Medicare Advantage (MA) business given the scheduled
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here